Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658471 · ClinicalTrials.gov registry record · NA
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
A NA study of Nicotine Dependence and Cardiovascular Risk Factors, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05658471: Recruiting NA study of Nicotine Dependence and Cardiovascular Risk Factors, sponsored by University of California, San Francisco.
NCT05658471 is a NA study of Nicotine Dependence and Cardiovascular Risk Factors that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658471, a NA study of Nicotine Dependence and Cardiovascular Risk Factors, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a crossover study that will examine use behaviors, chemical exposures, and biological effects of Standardized Research Electronic Cigarette (SREC) compared to usual brand e-cigarette use in natural or synthetic nicotine users.
Primary Outcome
The investigators will compare peak nicotine concentrations between SREC vs. EC use
Conditions Studied
Interventions
- OTHER Standardized Research E-Cigarette (SREC)
- OTHER Over the Counter E-Cigarette (EC)
- BEHAVIORAL Biological Samples
- OTHER Smoking-related Questionnaires
Study Locations (1)
California
- University of California, San Francisco - Tobacco Research Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT05658471 shows while recruiting
NCT05658471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 4 interventions - of which Standardized Research E-Cigarette (SREC) is the first listed.
NCT05658471 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05658471 about?
NCT05658471 is a clinical study titled "Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)". This is a crossover study that will examine use behaviors, chemical exposures, and biological effects of Standardized Research Electronic Cigarette (SREC) compared to usual brand e-cigarette use in natural or synthetic nicotine users.
What is the current status of trial NCT05658471?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-02-01. Estimated completion is 2026-01-31.
What conditions does trial NCT05658471 study?
This clinical trial studies the following conditions: Nicotine Dependence, Cardiovascular Risk Factors, Tobacco Toxicity.
What interventions are being tested in trial NCT05658471?
The interventions under investigation include: Standardized Research E-Cigarette (SREC) (OTHER), Over the Counter E-Cigarette (EC) (OTHER), Biological Samples (BEHAVIORAL), Smoking-related Questionnaires (OTHER).
Who is sponsoring clinical trial NCT05658471?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05658471 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05658471's enrollment target sits among peer trials
20 56th of 67 higher than 11 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
-
Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI